Cannabis Report
Home > Boards > US OTC > Medical - Healthcare > Progressive Care, Inc. (RXMD)


Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (10) | Next 10 | Previous | Next
ndww42 Member Profile
Followed By 48
Posts 2,631
Boards Moderated 0
Alias Born 10/13/14
160x600 placeholder
Progressive Care Inc. Announces Record Number of Prescriptions Filled and Strong Revenues During August 2018 InvestorsHub NewsWire - 9/18/2018 8:00:00 AM
Progressive Care Inc. Garners International News Coverage in Top Pharmacy Trade Publication for Its Efforts to Battle Opioid InvestorsHub NewsWire - 9/13/2018 9:47:41 AM
Progressive Care Announces Newly Redesigned Website for Wholly-Owned Subsidiary PharmCo, LLC InvestorsHub NewsWire - 9/10/2018 8:00:00 AM
S. Parikh Mars, CEO of Progressive Care Inc., is Featured in a New Audio Interview with InvestorsHub NewsWire - 8/29/2018 8:00:00 AM
Progressive Care Inc. Earns International Media Coverage in Top Industry Outlets on Its Healthcare Technology Expertise InvestorsHub NewsWire - 8/28/2018 11:05:26 AM
Progressive Care Inc. Subsidiary PharmCo, LLC Earns Top Performance Scores From Humana Inc. InvestorsHub NewsWire - 8/22/2018 8:00:00 AM
Progressive Care Inc. Reports 47% Increase in Prescriptions Filled During July 2018 MIAMI August 21, 2018 Progressive Care InvestorsHub NewsWire - 8/21/2018 8:00:00 AM
Progressive Care Inc. Reports Largest Six-Month Revenue Period in Company History in Q2 2018 Financial Filing InvestorsHub NewsWire - 8/14/2018 8:00:00 AM
Progressive Care Announces Pay-Off of Note to Chicago Venture Partners InvestorsHub NewsWire - 8/9/2018 8:00:00 AM
Progressive Care to Host Conference Call on Second Quarter 2018 Financial Results and Business Update on Aug. 14 InvestorsHub NewsWire - 8/7/2018 8:00:00 AM
Progressive Care Earns Coveted LegitScript Certification Verifying PharmCo Pharmacy is Safe and Credible Online Health Resource InvestorsHub NewsWire - 8/1/2018 8:00:00 AM
Progressive Care Subsidiary PharmCo Partners with Westchester General Hospital to Implement New DischargeRx Program InvestorsHub NewsWire - 7/26/2018 8:00:00 AM
Progressive Care Signs Two New 340B Contracts to Bring Discounted Prescription Programs to Non-Profit Healthcare Institutions InvestorsHub NewsWire - 7/19/2018 8:00:00 AM
Progressive Care Inc. Announces Month-End Sales Figures Showing Increase in Year-Over-Year Prescriptions Filled in June 2018 InvestorsHub NewsWire - 7/17/2018 3:02:16 PM
Progressive Care Launches New DischargeRX Program to Improve Engagement Between Patients and Hospitals InvestorsHub NewsWire - 7/13/2018 6:20:29 PM
S. Parikh Mars, CEO of Progressive Care, Discusses Recent Company and Industry News in New Audio Interview with SmallCapVoice InvestorsHub NewsWire - 7/3/2018 4:27:48 PM
Progressive Care Completes Acquisition of Touchpoint Pharmacy Expanding Company Footprint and Market Oppotunity MIAMI July X, InvestorsHub NewsWire - 7/2/2018 12:45:32 PM
`Progressive Care Inc. Signs New Investment Banking Agreement with The Benchmark Company, LLC InvestorsHub NewsWire - 6/27/2018 8:00:00 AM
Progressive Care Inc. Continues to See Strong Prescriptions Numbers and Overall Revenue in May 2018 InvestorsHub NewsWire - 6/14/2018 8:00:00 AM
Progressive Care Launches Opioid Alternative Treatment Campaign Aimed at Reaching Millions Affected by the Nationwide Epidemic InvestorsHub NewsWire - 6/12/2018 11:05:55 AM
Progressive Care Installs New TCGRx Pouch Packaging System in MiamiLeading Florida-Based Healthcare Services and Technology InvestorsHub NewsWire - 6/5/2018 8:00:00 AM
Progressive Care Begins Development of Proprietary Tele-pharmacy Software for Exclusive Use InvestorsHub NewsWire - 5/24/2018 8:00:00 AM
Progressive Care Purchases TCGRx Pouch Packaging System to Add to Expanding Robot Pharmacy Machinery Fleet InvestorsHub NewsWire - 5/21/2018 7:00:59 PM
Progressive Care Reports 30% Increase in Year-over-Year Prescriptions Filled During April 2018 InvestorsHub NewsWire - 5/17/2018 9:15:51 AM
Progressive Care Inc. Reports Largest Single Revenue Quarter in Company History InvestorsHub NewsWire - 5/15/2018 8:00:00 AM
ndww42   Sunday, 03/04/18 09:27:40 AM
Re: None
Post # of 101751 

February NET revenues: Week of March 12th or 19th or sooner - should be record net revenues again with possibly our second 2M+ month.

Acquisition details: With the latest announcement of the company's intent to purchase a pharmacy in Palm Beach County, we will see additional details around this purchase and what it means on the revenue side.

Audited Annual Report: Report is due 3/31 and will be the second audited year. Having two years of audited fins is the gold standard for institutional monies to flow in.

Conference call for shareholders: This occurs every quarter. Should happen around the release of the annual report.

March Numbers: Week of April 12th or 19th - should be record revenues again with possibly our third 2M+ month.

Additional technology partnerships / contracts: Progressive care is both a healthcare services and technology company. Expect additional PRs and contracts stating new revenues streams

Institutional buying: We've had what looks to be institutional buying recently and I would venture to guess we will receive more news about institutions covering us and major investments after we have our two years of audited financials in April.

Institutional stock coverage: Shital has made it clear that she'd like to have coverage of the stock by institutional analysts. We are seeing more and more signs of this and will hear more about it soon IMO.

Online Pharmacy / e-Commerce: With the news of Bitcoin and Amazon looking to get into the pharmacy space, expect additional news on RXMD about becoming a major online pharmacy.

CBD / MJ / HEMP: One of the latest major developments. Additional news about CBD and MJ will most likely be coming out in the next couple of months. They already stated they will have in-house compounding and R&D! This will boost sales big time as customers would like to see alternatives to addictive pain pills.

Tech / Tele-Pharm news: With the latest development of this being a tech play, we should hear more about their plan for tele-Pharmco and also we should hear from our NASDAQ independent board member on the latest developments.

Investor conferences to attract institutional investors: They will most likely PR these events over the coming months.

New 340B contracts: Over the next month or two we will most likely hear about new 340B contracts from multiple partners

New Long term care facility relationships: The company continues to be active in the community with doctors, patients and long term facilities. Expect additional partnerships on this front.

Achieve accreditation for non-sterile compounding: One the company's stated goals for 2018 is receiving accreditation for non-sterile compounding. This will actually allow them to make more money with more of a backing.

Traditional financing: Expect news of traditional financing over the coming year.

Opening more Pharmco Pharmacy Resource Centers in retirement and long term care communities: Another 2018 goal of the company. They will announce more resource centers to again strengthen their relationships in the community.

More out of state licenses: They've already obtained 14 state licenses where they can do business and planning to expand to more states. We may hear more about these revenue streams as they add to the bottom line.

Purdue sales rep team: We should be hearing more about the Purdue pharma sales force to join the team for conducting out of state sales

Expansion / M&A: We should be seeing additional PBM contracts related to their recent acquisition. I also believe we will hear more about additional acquisitions and other partnerships.

NASDAQ uplisting: With traditional financing, 2 locations and a much higher PPS, I expect to start to hear more about the company's plan to uplist to NASDAQ.

RXMD - King of the OTC

Best of the Best!
Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (10) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
Current Price
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist